AnaptysBio, Inc. ANAB Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$145.23M+11.2% | -$163.62M-27.1% | -$128.72M-123% | ||
| $559K-7.8% | $606K-7.1% | $652K-3.4% | $675K+9.0% | ||
| $36.07M+5.9% | $34.05M+2.5% | $33.21M+21.4% | $27.36M+78.2% | ||
| —— | —— | —— | —— | ||
| -$87.33M-158% | -$33.84M— | —— | $9.7M+305% | ||
| —— | -$3.2M— | —— | —— | ||
| —— | $33.91M+524% | $5.43M+900% | $543K+137% | ||
| $4.73M-54.1% | $10.31M-2.0% | $10.52M+320% | $2.51M+609% | ||
| $1.86M+4.1% | $1.79M+3.9% | $1.72M+3.9% | $1.66M+12.8% | ||
| -$1.93M-8.3% | -$1.78M-8.6% | -$1.64M-8.7% | -$1.51M— | ||
| $19.7M+115% | -$135.34M-12.0% | -$120.8M-64.1% | -$73.59M— | ||
| $87K-75.7% | $358K-55.6% | $807K+125% | $358K-73.8% | ||
| $196.41M-48.4% | $380.38M+25.2% | $303.92M-62.1% | $802.5M+576% | ||
| $424.53M-10.8% | $476.13M+5.9% | $449.48M+10.2% | $408.02M+157% | ||
| $228.03M— | —— | —— | -$416.34M— | ||
| $68.63M+14,950% | $456K— | —— | $0— | ||
| $14.26M+120% | $6.47M+162% | $2.47M-79.1% | $11.83M+363% | ||
| —— | —— | $0— | $0— | ||
| -$132.61M-204% | $127.05M+314% | -$59.3M-235% | $44.02M-82.6% | ||
| $115.12M— | —— | —— | -$437.18M-278% | ||
| $79.99M+89.9% | $42.13M— | $0— | $0— | ||
| —— | $33.91M+524% | $5.43M+900% | $543K— | ||
| —— | —— | —— | —— | ||
| -$1.93M-8.3% | -$1.78M-8.6% | -$1.64M-8.7% | -$1.51M— | ||
| —— | -$3.2M— | —— | —— | ||
| —— | $50.09M+177% | $18.08M-14.3% | $21.11M— | ||
| $1.86M+4.1% | $1.79M+3.9% | $1.72M+3.9% | $1.66M+12.8% | ||
| $424.53M-10.8% | $476.13M+5.9% | $449.48M+10.2% | $408.02M+157% | ||
| $0-100% | $103K+140% | $43K-87.2% | $336K+31.8% | ||
| $76.8M— | —— | $11.73M+374% | $2.47M— | ||
| —— | $7K— | —— | $154K— | ||
| -$1.93M-8.3% | -$1.78M-8.6% | -$1.64M-8.7% | -$1.51M— | ||
| $4.73M-54.1% | $10.31M-2.0% | $10.52M+320% | $2.51M+609% | ||
| —— | $0— | $0— | —— | ||
| —— | $0— | —— | —— | ||
| —— | $0— | —— | $0— | ||
| $19.61M+114% | -$135.7M-11.6% | -$121.61M-64.4% | -$73.95M— | ||
| $19.61M+114% | -$135.7M-11.6% | -$121.61M-64.4% | -$73.95M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AnaptysBio, Inc.'s cash flow data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.